Loading...
Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma
This phase I study evaluated the safety and efficacy of single-agent ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (aged 20-69 years and ineligible for chemotherapy using fludarabine or cyclophosphamide, or aged ≥70 years). Eight pa...
Na minha lista:
| Udgivet i: | J Clin Exp Hematop |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
JSLRT
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954169/ https://ncbi.nlm.nih.gov/pubmed/31866619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.19023 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|